SCLC cells overexpressing POU2F3 rely on the lineage transcription factors SOX9, ASCL2, and insulin-like growth factor 1 receptor (IGF-1R), suggesting potential vulnerability to tyrosine kinase inhibitors (4). The gene discussed is IGF1R; the disease is small cell lung carcinoma.